(NASDAQ:ZJK), Shenzhen, China, Jan. 22, 2025 (GLOBE NEWSWIRE) — ZJK Industrial Co. Ltd. (NASDAQ: ZJK) (“ZJK Industrial” or the “Company”), a high-tech precision parts and hardware manufacturer for artificial intelligence (AI) infrastructure and smart technologies, is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The […]

(NASDAQ:HEPA), EDISON, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic steatohepatitis (“NASH”), hepatocellular carcinoma (“HCC”), and other chronic liver diseases, announced the launch of a “best efforts” public offering of 27,692,310 shares of common stock (or pre-funded warrants in

(NASDAQ:PRPH), Transaction Eliminates More Than $20 Million in Debt, and Other Financial Obligations, Provides $2 million in Cash and Significantly Enhances the Company's Balance Sheet and Liquidity The Company will review with shareholders at 2:00 p.m. EST, details below. GARDEN CITY, NY, Jan. 22, 2025 (GLOBE NEWSWIRE) — ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or

(NASDAQ:SCLX), PALO ALTO, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and, following the formation of its proposed joint venture with IPMC Company, in neurodegenerative and

(NASDAQ:PLRX), Dr. Imbert brings 25 years of strategic clinical to commercial-stage manufacturing and drug development experience SOUTH SAN FRANCISCO, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, today announced the appointment

ORLANDO, Fla., Jan. 22, 2025 (GLOBE NEWSWIRE) — Arnie's, a bold new natural wellness brand inspired by Arnold Palmer's legacy of performance, embodies the unstoppable spirit that made him a global icon. Created in partnership with Arnold Palmer Enterprises and leading CBD Manufacturer Naternal, Arnie's debuts with a premium collection of topicals designed to help

(NYSE:HRB), KANSAS CITY, Mo., Jan. 22, 2025 (GLOBE NEWSWIRE) — The millions of Americans with revenue-generating side hustles and casual sellers may be in for a big surprise this January–an unexpected tax form called the 1099-K. Payment platforms, apps and online marketplaces must issue a Form 1099-K to anyone who received $5,000 or more in

(NASDAQ:ALXO), Mr. Shantharam is a proven biotech industry executive with over two decades of senior leadership experience in finance, commercial and corporate operations Dr. Klencke is a seasoned clinical leader in oncology drug development with more than 20 years of industry experience Dr. Takimoto brings a distinguished track record in oncology and drug development with

(NASDAQ:MATW), PITTSBURGH, Jan. 22, 2025 (GLOBE NEWSWIRE) — Matthews International Corporation (NASDAQ GSM: MATW) (“Matthews” or the “Company”) today sent a letter to its shareholders emphasizing the Company's commitment to long-term value creation. Key highlights from the letter include: Your Board has taken decisive actions to enhance long-term shareholder value – particularly the strategic sale

(NASDAQ:LSTA), Cohort A data to be presented in a poster session at the 2025 American Society of Clinical Oncology Gastrointestinal Cancers Symposium Data reported positive trend in overall survival, including 4 complete responses observed in the certepetide treatment group compared to none in placebo group Data from Cohort B expected in the coming months, with